Pacira BioSciences, Inc.

NasdaqGS:PCRX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

Location

United States

Market Cap

USD 1.11 B

Share Price

USD 24.81

Avg Daily Volume

673,904

Change (1 day)

-1.51%

Change (1 year)

101.87%

Change (YTD)

31.69%

Pacira BioSciences, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: -0.06%

Pacira BioSciences, Inc. EBITDA Margin is -0.06% for the Trailing 12 Months (TTM) ending June 30, 2025, a -100.25% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Pacira BioSciences, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 25.67%, a 55.60% change year over year.
Pacira BioSciences, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 16.49%, a -41.79% change year over year.
Pacira BioSciences, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was 28.34%, a 20.57% change year over year.
Pacira BioSciences, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was 23.50%, a 116.66% change year over year.